Coxibs and the endothelium

被引:5
作者
Verma, S [1 ]
Szmitko, PE [1 ]
机构
[1] Univ Toronto, Toronto Gen Hosp, Div Cardiac Surg, Toronto, ON M5G 2C4, Canada
关键词
D O I
10.1016/j.jacc.2003.08.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1754 / 1756
页数:3
相关论文
共 46 条
[1]   Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction [J].
Al Suwaidi, J ;
Hamasaki, S ;
Higano, ST ;
Nishimura, RA ;
Holmes, DR ;
Lerman, A .
CIRCULATION, 2000, 101 (09) :948-954
[2]   Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation - The nonsteroidal anti-inflammatory drugs in unstable angina treatment-2 (NUT-2) pilot study [J].
Altman, R ;
Luciardi, HL ;
Muntaner, J ;
Del Rio, F ;
Berman, SG ;
Lopez, R ;
Gonzalez, C .
CIRCULATION, 2002, 106 (02) :191-195
[3]  
Anderson TJ, 2003, CAN J CARDIOL, V19, P61
[4]   CLOSE RELATION OF ENDOTHELIAL FUNCTION IN THE HUMAN CORONARY AND PERIPHERAL CIRCULATIONS [J].
ANDERSON, TJ ;
UEHATA, A ;
GERHARD, MD ;
MEREDITH, IT ;
KNAB, S ;
DELAGRANGE, D ;
LIEBERMAN, EH ;
GANZ, P ;
CREAGER, MA ;
YEUNG, AC ;
SELWYN, AP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (05) :1235-1241
[5]   Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease - A reappraisal [J].
Baigent, C ;
Patrono, C .
ARTHRITIS AND RHEUMATISM, 2003, 48 (01) :12-20
[6]   Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages [J].
Baker, CSR ;
Hall, RJC ;
Evans, TJ ;
Pomerance, A ;
Maclouf, J ;
Creminon, C ;
Yacoub, MH ;
Polak, JM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :646-655
[7]   Cyclooxygenase-2 inhibitors and atherosclerosis [J].
Belton, O ;
Fitzgerald, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) :1820-1822
[8]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[9]   Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice [J].
Burleigh, ME ;
Babaev, VR ;
Oates, JA ;
Harris, RC ;
Gautam, S ;
Riendeau, D ;
Marnett, LJ ;
Morrow, JD ;
Fazio, S ;
Linton, MF .
CIRCULATION, 2002, 105 (15) :1816-1823
[10]   Selective COX-2 inhibition improves endothelial function in coronary artery disease [J].
Chenevard, R ;
Hürlimann, D ;
Béchir, M ;
Enseleit, F ;
Spieker, L ;
Hermann, M ;
Riesen, W ;
Gay, S ;
Gay, RE ;
Neidhart, M ;
Michel, B ;
Lüscher, TF ;
Noll, G ;
Ruschitzka, F .
CIRCULATION, 2003, 107 (03) :405-409